Recent advances in osteoimmunology suggest an important role of immune cells in the bone healing process, various bone diseases such as osteonecrosis, and in regulating the side effects of currently used high-dose BMP therapy for fracture repair; therefore, the pleotropic role of BMPs needs urgent further investigation. Here, CLN5 is linked to osteonecrosis.